Skip to content

Evaluate the efficacy of Rudrakshadi Yoga in the management of Ardhavbhedaka w.s.r. to Migraine

An Open Label Randomized Controlled Clinical Study to evaluate the efficacy of Rudrakshadi Yoga in the Management of Ardhavabhedaka w.s.r. to Migraine. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099985
Enrollment
30
Registered
2025-12-31
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

None listed

Sponsors

Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of age group above 18 years will be selected for the study. 2. Patients willing to participate and able to provide signed informed consent. 3. Patient with sign and symptoms of Ardhavbhedak given as per Ayurvedic and modern literature.

Exclusion criteria

Exclusion criteria: 1. History of hypersensitivity to any of the trial drug or other ingredients. 2. Individuals who have completed participation in any other clinical trial during the past six months. 3. Patients with status migrainosus, ophthalmic migraine or hemiplegic migraine. 4. Patients with chronic renal failure, diabetes mellitus, HTN will be excluded. 5. Any other condition which the principal investigator thinks may jeopardize the study

Design outcomes

Primary

MeasureTime frame
Relief in sign and symptoms of Migraine in patient Timepoint: 21 days

Secondary

MeasureTime frame
To evaluate the efficacy of Rudrakshadi yoga in the management of Migraine w.s.r. to ArdhavbhedakaTimepoint: 21 days

Countries

India

Contacts

Public ContactSangeeta

Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola

bhardwajvijayant@gmail.com9418017568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026